AQST - The Market Has Punished Aquestive Therapeutics - But Large Opportunities May Exist At Current Trading
- Recent disapproval from FDA regarding Libervant Buccal Film has seen investors react sourly over the last 2 weeks.
- Investors have punished the company, with the stock giving away ~-47% in returns over this period.
- Recent history shows the market can see the upside in Aquestive, and we have seen this situation before on the charts.
- Each plunge has seen a strong recovery, especially for those who have taken profits early, so there exists an exciting, albeit high-risk opportunity.
- We remain bullish on the company in the medium to long term, and feel the market will see the upside once again.
For further details see:
The Market Has Punished Aquestive Therapeutics - But Large Opportunities May Exist At Current Trading